Genomics For Life

Executive Summary

Genomics For Life is an Australian diagnostic pathology laboratory specializing in genomic testing across oncology, prenatal genetics, inherited diseases, and veterinary health. Founded in 2013 and headquartered in Milton (Brisbane), the company leverages next-generation sequencing (NGS) and non-invasive prenatal screening (NIPS) to deliver personalized treatment insights and carrier screening for up to 420 genes with fast turnaround times. As a commercial-stage private entity with 50–200 employees, it serves a growing demand for precision medicine in Australia. The company's diversified test portfolio and focus on clinical utility position it well in the competitive genomic diagnostics market. However, limited public information on financials and partnerships constrains visibility. We assign a conviction score of 60, reflecting solid operational footing balanced by uncertainty typical of private firms.

Upcoming Catalysts (preview)

• Q4 2026Expansion of carrier screening panel to 500+ genes70% success
• Q2 2026Partnership with a major Australian hospital network60% success
• Q3 2026Launch of veterinary genomic testing service line80% success